The Everything Spray

A molecule your neutrophils make for free, now $7 an ounce

Hypochlorous acid did not arrive in your feed the way most viral ingredients do. There was no launch, no ambassador, no unboxing. It leaked out of hospitals. It sat for years as a wound irrigant on surgical carts and in podiatry clinics, migrated to the back rooms of medspas where aestheticians misted it on faces after laser resurfacing, and then, somewhere around 2023, jumped the fence into consumer skincare and never looked back.

The pitch is almost too good. Your own white blood cells make this. It kills bacteria without antibiotics. It doesn't sting. You can spray it on acne, eczema, rosacea, perioral dermatitis, a fresh piercing, a sunburn, your gym bag, your dog. The hashtag went from roughly 1.4 million views in 2023 to more than 6 million the following year.²¹ The global market for hypochlorous acid sprays was around $1.42 billion in 2024 and is projected to nearly triple within the decade.²¹ One brand claims it sells a bottle every fifteen seconds, which is a marketing statistic and should be read as one.

Here is what makes this issue different from most of what I write. Hypochlorous acid is not a scam. The chemistry is real, the mechanism is real, the safety profile is genuinely excellent, and there is a substantial clinical literature behind it. I want to say that clearly at the top, because the rest of this piece is going to be difficult for the category.

The problem is that almost every one of those clinical trials was run on an open, infected, surgically debrided wound. And your face is not an open, infected, surgically debrided wound.

Electrified salt water, and why the pH on the bottle matters more than the price

The origin story is true. When a neutrophil engulfs a pathogen, the enzyme myeloperoxidase catalyzes a reaction between hydrogen peroxide and chloride ions, producing hypochlorous acid inside the phagolysosome. It is the principal microbicidal oxidant of your innate immune system. This is real biochemistry, taught in every immunology course.

It is also, I'd argue, the least useful true fact in the entire category. Your neutrophil generates a micromolar burst of HOCl in a sealed compartment a few micrometers across, directly against a bacterium it has already swallowed. That has approximately nothing to do with the physics of misting 150 parts per million of the same molecule onto intact stratum corneum from eight inches away. "Your body makes it" is a fine origin story and a terrible mechanism of action.

Commercial product is made by running an electrical current through dilute saline. Salt, water, electrodes. The industry calls the output "superoxidized solution" or "electrolyzed water," and the WHO application describes it as a "chemo-electrolytic process," noting that the older manufacturing route — acidifying sodium hypochlorite — "generated hazardous amounts of chlorine gas."²

Now the part that actually matters to a consumer, and that no influencer video I've seen has mentioned. Chlorine in water exists as either hypochlorous acid (HOCl) or hypochlorite ion (OCl⁻), and which one you get depends entirely on pH. HOCl is the potent, tissue-compatible species. OCl⁻ is bleach chemistry. The published stability window sits around pH 3.5 to 5.5, with maximum HOCl fraction near pH 5.^20,21 Above roughly pH 5.5, a growing share of your expensive facial mist converts to the thing that irritates eyes and airways.

The WHO application — written, remember, by proponents applying to have this listed — puts it more bluntly than any critic has:

The same document states that bleach "can be present at levels of 30% or more in hypochlorous acid solutions made or adjusted to pH 7."² Thirty percent. And the number of consumer facial sprays that print their pH on the label is, as far as I can determine, zero.

The claimed anti-inflammatory effects — reduced histamine activity, decreased IL-6 and IL-2, dampened mast cell degranulation, favorable keratinocyte migration — come almost entirely from cell culture.²⁰ The most cited neuronal work, Fukuyama and colleagues in Clinical and Experimental Allergy, showed HOCl reducing dorsal root ganglion neuron responses to IL-31 and histamine.⁶ That study was done in mice and in dishes. It is good preclinical work. It is not evidence about your face.

One claim I want to flag specifically because it circulates constantly: that HOCl degrades substance P, the neuropeptide involved in itch signaling. I could not locate a primary source demonstrating this. It appears in marketing copy and in secondary reviews that cite each other. Until someone produces the paper, treat it as folklore.

Where the data is genuinely good, and what it was measured on

I want to give the strong case its full weight, because it exists and it is not trivial.

The 2015 international consensus panel on HOCl in wound care rendered a graded verdict that remains the most honest single summary in the field: strong evidence for diabetic foot wounds, moderate evidence for septic surgical wounds, low evidence for venous leg ulcers and chronic wounds of mixed etiology, and no evidence for burns.² That is a serious, self-critical grading, and the trials behind the top two tiers are real.

That last finding is, in my reading, the truest thing about hypochlorous acid: its real competitive advantage is that it is unusually gentle for an antiseptic. It kills about as well as povidone-iodine and chlorhexidine while damaging fibroblasts and keratinocytes less. In a chronic wound you are trying to heal, that trade matters enormously. It's why clinicians reach for it.

The ophthalmology literature is the best-designed work adjacent to dermatology. Two 2023 randomized trials in blepharitis, one with 67 patients analyzed and one with 48 eyes, both found HOCl lid hygiene favorable on clinical scores with no adverse events reported.^9,10 Small, but properly randomized, with real endpoints.

Though even there, a caution: an in-vitro study in Clinical Optometry tested 0.1% HOCl — ten times the concentration in the leading ophthalmic product — against Demodex mites. After the full 90-minute exposure, 79% of the mites were still alive.¹¹ The mite-killing claim attached to these sprays is not supported.

And then there is the bleach bath conflation, which deserves its own paragraph because marketing depends on it. Dilute sodium hypochlorite baths for eczema are a different molecule from stabilized HOCl, but the two literatures get merged constantly. Worth knowing what that literature actually says.

The section where the file gets very thin

Now we cross from the hospital to the bathroom counter, and the evidence does not come with us.

Acne. There is not one published randomized controlled trial of a consumer hypochlorous acid facial spray for acne. Not a weak one. Zero. The two trials people cite are a 2009 study of "superoxidized solution" whose reported results compare against benzoyl peroxide at an undisclosed concentration⁷ — which makes the "as good as benzoyl peroxide" claim structurally unfalsifiable — and a 2021 split-face trial that was genuinely well-designed but used 0.005% sodium hypochlorite, in 40 patients, at a single center.⁸ That 40-patient study is the largest acne trial in this entire space, and it isn't even testing the molecule in your bottle.

Rosacea. No controlled trial exists. None. Dermatology Times, reviewing the category this past May, put it precisely: the mechanistic case is plausible, "but dedicated evidence is currently limited."²¹

Seborrheic dermatitis. One conference poster, 25 patients, no control group, presented in 2014.¹⁹ That is the complete dedicated human evidence base.

Atopic dermatitis with HOCl specifically. The widely-repeated "itch relief in three days" figure traces to a poster presented at a 2017 dermatology conference. Thirty subjects: 20 received a HOCl gel, 10 received nothing at all.⁵ Not a vehicle, not a placebo — no treatment. On a purely subjective itch endpoint. Describing that trial as "investigator-blinded" is accurate and beside the point; the patient rating her own itch knew perfectly well whether she'd been given something. I have not been able to locate a peer-reviewed publication of it.

Post-procedure healing — the use case the entire aesthetics industry has standardized on. The 2025 series in the Journal of Cosmetic Dermatology enrolled ten patients, open-label, with no control arm.¹⁸ The other pillar, a widely-cited 2020 paper titled "the future gold standard for wound care and scar management," is an expert panel consensus containing no original patient data whatsoever.¹⁷ An industry practice adopted more or less universally, resting on a ten-person uncontrolled series and a panel opinion.

Barrier repair. This one deserves its own sentence. There is no study. Not a weak study, not a small study, not a poster — nothing. No transepidermal water loss measurement, no corneometry, no ceramide or filaggrin endpoint has ever been published for hypochlorous acid on human skin. The claim appears to have been generated entirely by marketing. It is also mechanistically strange: HOCl is a non-selective oxidant, and nothing about oxidizing the stratum corneum obviously repairs it.

And the extrapolation being asked of you is larger than it looks. An open diabetic ulcer has no barrier, a high microbial burden, and a healing process stalled in the inflammatory phase. Your cheek has an intact barrier, a commensal microbiome doing useful work, and no stalled anything. The logic — it helps ulcers, therefore it will help faces — is an assumption wearing the clothes of a finding.

Nobody has published a microbiome study of chronic daily HOCl misting on healthy facial skin, either. A potent, non-selective oxidant does not distinguish C. acnes from S. epidermidis. Whether that matters over months of twice-daily use is simply unknown.

You cannot tell whether the bottle still works

Here is the part of the story that the influencer content omits completely, and it may be the most practically important thing in this issue.

Hypochlorous acid degrades. Cosmetic chemist Victoria Fu, who reviewed the leading brands, lists the enemies: pH drift, ultraviolet light (depletion "on the order of hours"), heat, dissolved metal ions, oxygen, and organic load — noting that "the smallest impurity in water can affect HOCl stability."²² Published shelf-life estimates run 12 to 24 months sealed and stored cool in opaque packaging, but only 30 to 90 days after opening under realistic conditions: air exchanging through the spray pump, bathroom humidity, temperature swings, a nozzle that touches your skin.²¹

There's a counterintuitive wrinkle, too. Higher-concentration formulations above 500 ppm appear to degrade faster than moderate 200 to 300 ppm products.²¹ More is not better here, which inverts the usual consumer heuristic.

Now, the surprise that cuts against the easy skeptical story. I expected to find that consumer sprays were homeopathically dilute compared to medical product. They aren't. Labeled concentrations across the major brands run roughly 140 to 200 ppm — squarely inside the 100 to 200 ppm range of wound care solutions cleared for the US market.^2,22 The concentration is not the problem.

The problem is that nobody has verified it. The entire hard stability dataset in the WHO application is a single conference abstract, which reported that after 30 days at 70°C in sealed glass, active chlorine fell from 190 ppm to 151 ppm — a 20.5% loss, presented as evidence of stability.^2,24 That document contains no light-sensitivity data at all, for a molecule that degrades in hours under UV.

I searched for any published independent market surveillance assay of consumer HOCl skincare — anyone testing whether the bottles on shelves contain their labeled ppm. I could not find one. Fu, who tested the top three brands, concluded that "without making stability testing data public, you can't" identify a best product, and identified a single brand as "essentially the only brand that disclosed some of their testing."²²

So: a molecule that degrades within hours in sunlight, whose degradation product is dilute bleach, sold in packaging that displays no pH, no ppm, and no manufacture date, from companies that with one exception publish no stability data, with no independent verification anywhere. You are being asked to take it on faith that what you're spraying is still what you paid for.

What you paid for, incidentally, is electrified salt water. The WHO application estimates bulk HOCl can be produced for "less than one Euro per wholesale litre."² A litre is 33.8 ounces. At $7.00 an ounce, that same litre retails for roughly $237. Packaging, formulation, testing and margin are all legitimate costs. A markup in the neighborhood of 200× is still worth saying out loud.

FDA-cleared is not FDA-approved, and the gap is the whole business model

Scroll the marketing and you will see "FDA-cleared" everywhere, and not infrequently "FDA-approved," which is a different thing entirely.

A 510(k) clearance is a premarket notification. The manufacturer demonstrates that its device is substantially equivalent to a predicate device already on the market. It requires no demonstration of clinical efficacy. Devices are cleared. Drugs are approved. The distinction is not pedantry — it is the difference between "someone showed this works" and "someone showed this resembles something already sold."

The clearances are real. Microcyn Skin and Wound Care Solution was cleared in March 2007; Vashe followed in 2013; Sonoma Pharmaceuticals obtained a clearance in September 2024 that added over-the-counter indications for the face, eyelid and eyelashes, which is the regulatory hook the consumer category now hangs on.^2,21

But note the tier confusion this enables. The prestige products — Vashe, Microcyn, Avenova, CLn — are 510(k)-cleared devices. The sprays going viral on TikTok are, for the most part, regulated as cosmetics: no premarket review, no efficacy requirement, no mandated stability testing, no legal ability to make disease claims. The pitch borrows the authority of the device tier for a product sitting in the cosmetic tier. No hypochlorous acid product holds an FDA drug approval for any dermatologic indication.

Which brings us to the finding that reframes everything, and that I have not seen reported anywhere in consumer coverage of this ingredient.

The WHO Expert Committee on the Selection and Use of Essential Medicines has evaluated hypochlorous acid for topical antisepsis and wound care three times. Rejected in 2017 for inadequate evidence. Rejected in 2021 — on an application submitted by Briotech, a manufacturer of HOCl products. Rejected again in 2025, with the Committee noting that "no new evidence of benefits and harms of hypochlorous acid solution was presented, only the evidence already evaluated by the 2021 Expert Committee," and concluding against listing "because of inconclusive evidence for benefit."¹

Hypochlorous acid was added to the Essential Medicines List in 2025. As an environmental disinfectant. For surfaces.

Two ratings, because one would be dishonest

Before the verdict, the strongest thing I can say in this molecule's favor, and I want it on the record: the safety data is genuinely reassuring. The WHO harms review states that clinical adverse events from exposure to pure hypochlorous acid at pH 4.0 to 5.33 "have not been recorded in the medical literature."¹ It's negative on Ames and micronucleus genotoxicity testing. Mice drinking it for eight weeks showed no systemic effects.²³ It's less cytotoxic than povidone-iodine and chlorhexidine.¹⁵ A century of use has produced no documented microbial resistance, which makes mechanistic sense for something that kills by oxidative membrane disruption rather than enzyme inhibition. I found no published case reports of allergic contact dermatitis to it.

The one soft spot in the safety file is inhalation, which is awkward for an aerosol you point at your face. The entire human dataset is a self-selected employer-offered volunteer survey — 450-plus exposures, self-reported by questionnaire, no control group, 84% male, no spirometry.² That is not a reason for alarm. It is a reason not to claim the question has been studied.